NeuroMetrix, Inc. Announces Initial Commercial Shipment of SENSUS™ Pain Management System

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com, a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, reported today that it had initiated commercial shipment of its SENSUS Pain Management System which received final FDA clearance on November 28, 2012. SENSUS is a transcutaneous electrical nerve stimulator intended for the symptomatic relief and management of chronic intractable pain. It offers physicians and their patients advanced nerve stimulation technology in a light weight, low profile device worn on the upper calf that is activated by the press of a single button.

Back to news